系统性硬化症患者主要不良心血管事件风险:一项全国性人群队列研究
基于台湾全民健康保险研究数据库的全国性人群队列研究,采用倾向评分1:2匹配纳入1379例系统性硬化症患者和2758名非患者,发现系统性硬化症与主要不良心血管事件风险无显著关联(aHR 1.04;95%CI 0.77-1.42),但与心肌梗死和外周动脉闭塞性疾病风险升高相关,与缺血性卒中无关。
要点
- 系统性硬化症与主要不良心血管事件风险无显著关联(aHR 1.04;95%CI 0.77-1.42)。
- 系统性硬化症患者心肌梗死风险升高(IRR 1.76;95%CI 1.08-2.86)。
- 系统性硬化症患者外周动脉闭塞性疾病风险升高(IRR 3.67;95%CI 2.84-4.74)。
核心结论
- 台湾系统性硬化症患者主要不良心血管事件风险未显著增加,但心肌梗死和外周动脉闭塞性疾病风险较高,缺血性卒中风险未升高。
- 研究识别了系统性硬化症患者主要不良心血管事件的独立相关因素。
研究设计与样本
- 全国性、人群为基础的队列研究,使用台湾全民健康保险研究数据库。
- 采用1:2倾向评分匹配,纳入1379例系统性硬化症患者和2758名非系统性硬化症个体。
- 使用多变量Cox比例风险回归模型并调整时变协变量,评估系统性硬化症与主要不良心血管事件的关联及患者中的危险因素。
主要发现
- 系统性硬化症与主要不良心血管事件风险无显著关联(aHR 1.04;95%CI 0.77-1.42)。
- 系统性硬化症与心肌梗死风险升高相关(IRR 1.76;95%CI 1.08-2.86)。
- 系统性硬化症与外周动脉闭塞性疾病风险升高相关(IRR 3.67;95%CI 2.84-4.74)。
- 系统性硬化症与缺血性卒中风险无显著关联(IRR 0.89;95%CI 0.61-1.29)。
- 系统性硬化症患者中与主要不良心血管事件独立相关的因素包括年龄(aHR 1.02)、男性(aHR 2.01)、居住郊区(aHR 2.09)、居住农村(aHR 3.00)、瓣膜性心脏病(aHR 4.26)、类风湿关节炎(aHR 2.14)、使用氯吡格雷(aHR 26.65)和使用阿司匹林(aHR 5.31)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to assess the incidence and risk factors of major adverse cardiovascular events (MACEs) in patients with systemic sclerosis (SSc). METHODS: We conducted a nationwide, population-based, cohort study using Taiwan's National Health Insurance Research Database. We performed propensity score matching (PSM) using a 1:2 ratio, resulting in inclusion of 1379 patients with SSc and 2758 non-SSc individuals in the analysis. We assessed the association between SSc and MACEs, using the multivariable Cox proportional hazard regression model with adjustment of time-dependent covariates, and investigated risk factors for MACEs in patients with SSc, shown as adjusted hazard ratios (aHRs) with 95% CIs. RESULTS: SSc was not significantly associated with the risk of MACEs (aHR 1.04; 95% CI 0.77-1.42). Nevertheless, SSc was associated with increased risk of myocardial infarction [incidence rate ratio (IRR) 1.76; 95% CI 1.08-2.86] and peripheral arterial occlusion disease (IRR 3.67; 95% CI 2.84-4.74) but not of ischaemic stroke (IRR 0.89; 95% CI 0.61-1.29). Factors independently associated with MACEs in SSc patients included age (aHR 1.02), male gender (aHR 2.01), living in a suburban area (aHR 2.09), living in a rural area (aHR 3.00), valvular heart disease (aHR 4.26), RA (aHR 2.14), use of clopidogrel (aHR 26.65), and use of aspirin (aHR 5.31). CONCLUSIONS: The risk of MACEs was not significantly increased in Taiwanese patients with SSc, and our investigation effectively identified the factors independently associated with MACEs in SSc patients. Additionally, patients with SSc exhibited higher risks of myocardial infarction and peripheral arterial occlusion disease but not of ischaemic stroke.
引用
- Yen TH, Chen YW, Hsieh TY, et al. The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study. Rheumatology (Oxford). 2024. PMID: 37695290. doi:10.1093/rheumatology/kead464
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。